Cancer diagnostics often begin with a biopsy and histopathologic examination, from the basis of physical examination and medical history. Sometimes the first indication is an abnormal laboratory test result (eg, anemia resulting from colon cancer).
-
Date: May 17, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) Monoclonal antibody (mAb) is generated from a single clone of an antibody-producing cell and recognizes one specific epitop...
A hypoxic tumour microenvironment is a feature of solid tumours. Many tumour types contain high fractions of hypoxic tissue. The relationship between high levels of tumour hypoxia and a poor...
The human genome encodes 25,000 genes. But the biological complexity inherent in polygenic traits is a clear sign that the whole is greater than the sum of its parts. Genes, gene products, a...
Currently over 95 % of pharmaceutical products and transport fuels are derived from petroleum. Sustainable alternatives are critical to achieving net-zero emissions without detriment to qual...
Date: March 29, 2022 Time: 09:00am (PDT), 12:00pm (EDT), 17:00 (GMT) Advances in molecular and immunodiagnostics are enabling a personalized, high-precision approach to health in many clin...
Date: March 24, 2022 Time: 8:00am (PST), 11:00am (EST), 4:00pm (GMT) Key to precision oncology is the development of expert databases that organize and standardize information on cancer-rel...
Date: March 08, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CEST) SARS-CoV-2 causes COVID-19, a potentially lethal viral infection that can cause sever...
Date: March 01, 2022 Time: 10:00am (PST), 1:00pm (EST), 7:00pm (CEST) The high mortality of COVID-19 is mostly attributed to acute respiratory distress syndrome (ARDS), whose histopathologic...
Date: February 24, 2022 Time: 08:00am (PST), 11:00am (EST) Fume hoods are often the largest consumers of energy in a lab space and are consequent...
High-throughput sequencing technology such as RNASeq and whole genome sequencing has enabled deep characterization of health and disease states. Biomarker discovery by these means has only h...
Cancer still accounts for nearly 1 in every 4 deaths worldwide. New immunotherapies have the power to induce durable responses in patients with fatal cancers, but only a small percentage of...